Compare CRL & CFLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CRL | CFLT |
|---|---|---|
| Founded | 1947 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.0B | 7.7B |
| IPO Year | 2000 | 2021 |
| Metric | CRL | CFLT |
|---|---|---|
| Price | $195.57 | $29.97 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 32 |
| Target Price | ★ $191.00 | $29.93 |
| AVG Volume (30 Days) | 794.4K | ★ 18.7M |
| Earning Date | 11-05-2025 | 10-27-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $4,023,704,000.00 | $1,113,149,000.00 |
| Revenue This Year | N/A | $22.76 |
| Revenue Next Year | $1.66 | $16.57 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 21.57 |
| 52 Week Low | $91.86 | $15.64 |
| 52 Week High | $200.58 | $37.90 |
| Indicator | CRL | CFLT |
|---|---|---|
| Relative Strength Index (RSI) | 65.20 | 77.38 |
| Support Level | $194.50 | $29.96 |
| Resistance Level | $200.58 | $30.15 |
| Average True Range (ATR) | 5.45 | 0.38 |
| MACD | 1.24 | 0.45 |
| Stochastic Oscillator | 79.95 | 96.96 |
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Confluent Inc provides a data streaming platform that enables customers to connect their applications, systems, and data layers and can be deployed as a fully managed cloud-native software-as-a-service (SaaS) offering. Its products include Confluent Cloud, a self-managed software offering, Confluent Platform, a managed service offering where the raw data resides inside a customer's cloud environment, and WarpStream, among others. Confluent also offers professional services and education services. The company generates revenue from the sale of subscriptions and services. Geographically, it generates a majority of its revenue from its business in the United States and the rest from International markets.